Concepedia

Clare Taylor

CT

13

Publications

4.7K

Citations

11

H-Index

2001

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

University of Edinburgh

University College London

Cornell University

Clare Taylor is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, cellular therapies, and cell transplantation.

Top concepts

Publications per year

2001–2025

13

Publications

13

CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia

Renier J. Brentjens, Marco L. Davila, Isabelle Rivière et al. · Science Translational Medicine · 2013 · 2.1K citations · Full text

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

Renier J. Brentjens, Isabelle Rivière, Jae H. Park et al. · Blood · 2011 · 1.3K citations · Full text

Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells

Tanzina Haque, Gwen Wilkie, Clare Taylor et al. · The Lancet · 2002 · 363 citations

, , +9

Manufacturing Validation of Biologically Functional T Cells Targeted to CD19 Antigen for Autologous Adoptive Cell Therapy

Daniel Hollyman, Jolanta Stefanski, Mark Przybylowski et al. · Journal of Immunotherapy · 2009 · 316 citations · Full text

, , +13

Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy

Clare Taylor, Dawn L. Hershman, Nina Shah et al. · Clinical Cancer Research · 2007 · 213 citations

Rows per page

1–5 of 13